Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-06

Clinical Trial Update: Light, Ion, and Fluoxetine Efficacy (LIFE) in Depression [Phase 3]

View source ↗

Summary

Phase 3 LIFE trial evaluating light therapy, Ion therapy, and fluoxetine for major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluoxetine (Fluoxetine)

Snippet

Sponsor: University of British Columbia | Conditions: Major Depressive Disorder (MDD) | Phase 3 | Status: COMPLETED